Rationale and Design of the Lung Cancer Screening Implementation. Evaluation of Patient-Centered Care Study.
Repository Usage Stats
Screening for lung cancer using low-dose computed tomography has been demonstrated to reduce lung cancer-related mortality and is being widely implemented. Further research in this area is needed to assess the impact of screening on patient-centered outcomes. Here, we describe the design and rationale for a new study entitled Lung Cancer Screening Implementation: Evaluation of Patient-Centered Care. The protocol is composed of an interconnected series of studies evaluating patients and clinicians who are engaged in lung cancer screening in real-world settings. The primary goal of this study is to evaluate communication processes that are being used in routine care and to identify best practices that can be readily scaled up for implementation in multiple settings. We hypothesize that higher overall quality of patient-clinician communication processes will be associated with lower levels of distress and decisional conflict as patients decide whether or not to participate in lung cancer screening. This work is a critical step toward identifying modifiable mechanisms that are associated with high quality of care for the millions of patients who will consider lung cancer screening. Given the enormous potential benefits and burdens of lung cancer screening on patients, clinicians, and the healthcare system, it is important to identify and then scale up quality communication practices that positively influence patient-centered care.
Tomography, X-Ray Computed
Early Detection of Cancer
Published Version (Please cite this version)10.1513/annalsats.201705-378sd
Publication InfoMiranda, Leah S; Datta, Santanu; Melzer, Anne C; Wiener, Renda Soylemez; Davis, James M; Tong, Betty C; ... Slatore, Christopher G (2017). Rationale and Design of the Lung Cancer Screening Implementation. Evaluation of Patient-Centered Care Study. Annals of the American Thoracic Society, 14(10). pp. 1581-1590. 10.1513/annalsats.201705-378sd. Retrieved from https://hdl.handle.net/10161/21397.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Assistant Professor in Medicine
BS, MBA, MS from Florida State University; PhD, University of North Carolina at Chapel Hill. After earning his undergraduate degree in chemistry, Dr. Datta went on to earn an MBA in finance and a masters degree in economics at Florida State University. He then went to the University of North Carolina— Chapel Hill School of Public Health to earn a doctorate in health policy and administration with a concentration in health economics. Dr. Datta began his research career as an Associate in Re
Associate Professor of Medicine
Dr. James Davis is a practicing physician of Internal Medicine, and serves as the Medical Director for Duke Center for Smoking Cessation, Director of the Duke Smoking Cessation Program and Co-Director of the Duke-UNC Tobacco Treatment Specialist Credentialing Program. His research focuses on development of new pharmaceutical treatments for smoking cessation. He is principal investigator on several trials including a study on “adaptive” smoking cessation and several trials
Associate Professor of Surgery
Alphabetical list of authors with Scholars@Duke profiles.